Skip to main content

Table 2 Demographics and low back pain characteristics of study participants

From: Concordance of patient beliefs and expectations regarding the management of low back pain with guideline recommendations – a cross-sectional study in Germany

Characteristic All participants Participants with current low back pain
Age (median, Q1; Q3) a 57 (40; 67) a 58 (48; 68) d
Male (n, %) 381/974 (39.1) 76/211 (36)
Education (n, %)
 < 10 years of school 198/961 (20.6) 55/207 (26.6)
 10 years of school 519/961 (54.0) 110/207 (53.1)
 > 10 years of school 244/961 (25.4) 42/207 (20.3)
Self-assessed health status, n (%) b
 Excellent 23/954 (3.3) 1/208 (0.3)
 Very good 126/954 (17.2) 13/208 (9.3)
 Good 527/954 (54.6) 85/208 (44.8)
 Fair 234/954 (21.0) 86/208 (35.6)
 Poor 44/954 (4.0) 23/208 (10.0)
Low back pain (n, %) b
 Currently experiencing low back pain 211/960 (20.6)
 Low back pain in the last 12 months 501/960 (54.8)
 Low back pain not in the last 12 months 248/960 (24.6)
Only participants with current low back pain or during the last 12 months (n = 712)
 Presenting at the GP for low back pain (n, %) b 96/690 (12.5) 71/203 (33.8)
 Low back pain on a 10-point scale in the last 12 months b
 Median (Q1; Q3) 5.0 (3; 6) e 5.0 (4; 7) f
  • Mild (0–5) 439/687 (64.7) 103/203 (54.5)
  • Moderate (6, 7) 162/687 (22.9) 56/203 (26.1)
  • Severe (8–10) 86/687 (12.4) 44/203 (19.5)
 Analgesics for low back pain in the last 12 months (n, %) b 406/712 (56.7) 157/211 (73.9)
 Interference of daily activity on a 10-point scale in the last 12 months (median, Q1; Q3) 4.0 (3; 6) c 5.0 (3; 7) g
 Imaging for low back pain in the last 12 months (n, %) b 194/705 (25.1) 88/207 (39.6)
Surgery for LBP (n, %) b 61/968 (4.7) 25/210 (9.6)
Injection therapy (n, %) b 472 /961 (43.9) 148/2010 (65.9)
  1. a missing = 4, b weighted percentage, c missing = 42, d missing = 2, e missing = 25, f missing = 8, g missing = 7
  2. Q1 First quartile, Q3 Third quartile